Skip to main content
. Author manuscript; available in PMC: 2021 Aug 1.
Published in final edited form as: Clin Trials. 2021 May 27;18(4):391–397. doi: 10.1177/17407745211018613

Figure 1.

Figure 1.

Settings are illustrated for use of the proposed hybrid analyses, where tR denotes the calendar date when it is no longer proper to continue randomization to placebo, and tF denotes the calendar date when it would no longer be proper for participants randomized to placebo to remain on placebo and in follow-up.

The solid lines denote calendar times when participants are being randomized to an arm, while the dotted lines denote when follow-up is continued for those randomize before tR